Rosa Amoroso Selected Research

prolinamide

1/2019	The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro.
5/2018	Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosa Amoroso Research Topics

Disease

6	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2016
6	Neoplasms (Cancer) 07/2020 - 01/2017
5	Glioma (Gliomas) 07/2020 - 06/2017
4	Inflammation (Inflammations) 07/2021 - 01/2019
3	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2016
3	Paraganglioma (Paragangliomas) 05/2020 - 11/2018
2	Mycoses (Diseases, Fungus) 12/2021 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 11/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019 - 04/2019
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 11/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 08/2017
2	Dyslipidemias (Dyslipidemia) 01/2019 - 09/2015
1	Carcinogenesis 05/2022
1	Triple Negative Breast Neoplasms 05/2022
1	Infections 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 07/2021
1	Polyploidy 12/2019
1	Obesity 07/2019
1	Hypertension (High Blood Pressure) 07/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Infertility (Sterility) 01/2019
1	Diabetes Mellitus 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Cholestasis 10/2018
1	Gallstones (Gallstone) 10/2018
1	Glioblastoma (Glioblastoma Multiforme) 06/2017
1	Pathologic Processes 10/2016
1	Metabolic Diseases (Metabolic Disease) 05/2016
1	Cognitive Dysfunction 01/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Insulin Resistance 09/2015

Drug/Important Bio-Agent (IBA)

10	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 05/2016
7	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2021 - 05/2018
4	Fibric Acids (Fibrates)IBA 04/2019 - 09/2015
3	LigandsIBA 01/2022 - 09/2015
3	Aromatase InhibitorsIBA 12/2021 - 01/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2021 - 06/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Biological ProductsIBA 12/2021 - 05/2018
2	Aromatase (CYP19)IBA 12/2021 - 11/2021
2	EnzymesIBA 07/2021 - 10/2016
2	acetamidineIBA 06/2020 - 01/2019
2	GW 6471IBA 05/2020 - 11/2018
2	Pharmaceutical PreparationsIBA 12/2019 - 01/2016
2	prolinamideIBA 01/2019 - 05/2018
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2016
2	LipidsIBA 01/2019 - 10/2018
2	Hormones (Hormone)IBA 06/2017 - 01/2016
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 11/2016 - 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2022
1	Histone Deacetylase InhibitorsIBA 05/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 04/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	IndazolesIBA 12/2021
1	TriazolesIBA 12/2021
1	Free RadicalsIBA 07/2021
1	compound 17IBA 07/2020
1	benzimidazoleIBA 12/2019
1	Gemcitabine FDA Link 12/2019
1	parbendazoleIBA 12/2019
1	BenzimidazolesIBA 12/2019
1	AnthelminticsIBA 12/2019
1	CM544IBA 01/2019
1	SolutionsIBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Antifungal AgentsIBA 01/2019
1	AmidesIBA 01/2019
1	benzothiazoleIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 11/2018
1	SteroidsIBA 06/2017
1	StilbenesIBA 01/2017
1	ZincIBA 10/2016
1	Matrix Metalloproteinases (MMPs)IBA 10/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2016
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2016
1	Therapeutic UsesIBA 09/2015
1	Triglycerides (Triacylglycerol)IBA 09/2015

Therapy/Procedure

7	Therapeutics 05/2022 - 11/2016
2	Drug Therapy (Chemotherapy) 05/2022 - 01/2019
1	Radiotherapy 06/2017